Diastolic dysfunction may influence perioperative outcome, early graft function, and long-term survival. We compared the outcomes of double lung transplantation (DLTx) for patients with pulmonary arterial hypertension (PAH) with preoperative left ventricular (LV) diastolic dysfunction with the outcomes of patients without diastolic dysfunction. Of 116 consecutive patients with PAH (who underwent transplantation between January 1995 and December 2013), 44 met our inclusion and exclusion criteria. Fourteen (31.8%) patients with diastolic dysfunction pretransplantation had a higher body mass index (29 . There was no effect on development of primary graft dysfunction or intensive care unit/hospital survival. One-year survival was worse (hazard ratio [HR] 4.45, 95% confidence interval [CI] 1.3-22, p = 0.02). Diastolic dysfunction was the only variable that correlated with overall survival (HR 5.4, 95% CI 1.3-22, p = 0.02). Diastolic dysfunction leads to early postoperative morbidity and worse survival in patients with PAH after DLTx.
Diastolic dysfunction may influence perioperative outcome, early graft function, and long-term survival. We compared the outcomes of double lung transplantation (DLTx) for patients with pulmonary arterial hypertension (PAH) with preoperative left ventricular (LV) diastolic dysfunction with the outcomes of patients without diastolic dysfunction. Of 116 consecutive patients with PAH (who underwent transplantation between January 1995 and December 2013), 44 met our inclusion and exclusion criteria. Fourteen (31.8%) patients with diastolic dysfunction pretransplantation had a higher body mass index [p = 0.08]). There was no effect on development of primary graft dysfunction or intensive care unit/hospital survival. One-year survival was worse (hazard ratio [HR] 4.45, 95% confidence interval [CI] 1.3-22, p = 0.02). Diastolic dysfunction was the only variable that correlated with overall survival (HR 5.4, 95% CI 1.3-22, p = 0.02). Diastolic dysfunction leads to early postoperative morbidity and worse survival in patients with PAH after DLTx.
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Introduction
Despite advances in understanding and treatments, for many, pulmonary arterial hypertension (PAH) remains progressive and lethal. Lung transplantation (LTx) is the only treatment for patients with advanced PAH who fail medical therapy (1) . PAH comprises a group of conditions that share a characteristic pulmonary vasculopathy and clinical progressive right ventricular failure (2) . The populations of patients with PAH undergoing LTx can be classified into three main categories: idiopathic PAH (IPAH), PAH associated with connective tissue disease (CTD-PAH), and PAH associated with congenital heart disease (CHD-PAH). Although many patients with CHD-PHD undergo heartlung transplantation (HLTx), patients with IPAH and CTD-PAH usually receive a double LTx (DLTx) (3).
The pathophysiological changes occurring in advanced PAH that define the severity of the disease ultimately relate to functional changes of the right ventricle (RV). The increase in RV afterload leads to compensatory modifications in the RV and eventually results in a disruption of the normal ventricle-arterial coupling and RV failure. The changes in RV function include RV wall hypertrophy, RV and right atrial dilatation, and bowing of the interventricular septum. Importantly, these changes have been shown to have an adverse influence on left ventricular (LV) diastolic function (4, 5) .
While pre-LTx RV failure might not affect the post-LTx outcome due to the ability of the RV to regain normal anatomy and function after LTx, it is unknown whether LV diastolic dysfunction affects the post-LTx clinical course. Indeed, there has been concern that this abnormal diastolic function may persist in the postoperative period and contribute to pulmonary edema. Moreover, post-LTx LV recovery has been suggested to be delayed or even absent in recent studies (6) (7) (8) (9) (10) .
Some reports (1, 11) suggest that outcomes after HLTx may be better than those after LTx, for patients with severe RV failure. Although some of the acute morbidity following LTx may be related to persistent RV dysfunction before remodeling can occur, we wondered if LV diastolic dysfunction had an impact on the acute clinical course and longer-term outcomes after LTx. To address this question, we conducted a retrospective cohort study of patients undergoing LTx for PAH to compare the outcomes of patients who had evidence of pre-operative LV diastolic dysfunction outcomes of patients without evidence of diastolic dysfunction. We also reviewed postoperative echocardiography data to determine if the LV diastolic dysfunction persisted after LTx.
Material and Methods

Data collection
We reviewed the records of 116 consecutive patients with PAH who underwent LTx at the Toronto General Hospital between January 1995 and December 2013. We did not include patients who died while on the waiting list. PAH was defined according to the updated clinical classification of group I PH criteria (2, 12) . Our cohort included patients with IPAH, heritable PAH, PAH related to drugs and toxins, and CTD-PAH. All patients fulfilled the criteria for PAH at the time of their diagnosis, including a heart catheterization measurement of a pulmonary capillary wedge pressure <15 mmHg. Relevant patient demographic information was collected at the time of listing for LTx. Clinical and echocardiographic information was collected from the pretransplantation assessment records. Patients with PAH associated with HIV infection, portal hypertension, and schistosomiasis were excluded from this study. Patients with CHD-PAH were excluded, because the heart dysfunction of these patients might be a consequence of the anatomical heart abnormality, and not necessarily the PAH, and because most of the patients with CHD-PAH are referred for HLTx. Patients with significant (grade 3 or 4) LV systolic dysfunction, moderate or greater mitral regurgitation or stenosis or moderate or greater aortic insufficiency or stenosis, pericardial disease, or cardiomyopathy are not candidates for LTx and were not included in the cohort. The study was approved by the University Health Network Research Ethics Board, which waived the need for informed consent to retrieve patient data.
Evaluation of LV diastolic dysfunction pretransplantation
The LV and RV dimensions and functions are routinely assessed with the use of echocardiography in all patients before LTx. Standard parasternal long-axis and apical four-chamber view had been performed on all 44 of the patients. Diastolic dysfunction (DDF) was defined as a normal ejection fraction with signs of restrictive filling LV (Appendix S1). Specifically, the patient was diagnosed with DDF if they met any one of the following: (1) an increase in the isovolumic relaxation time adjusted to age, (2) reduction in the E:A ratio adjusted to the age of the patient, or (3) increase in deceleration time relative to age (13) (14) (15) . We did not include in this definition patients with impaired relaxation (grade 1) DDF on echocardiography (16) .
Statistical analysis
Our primary outcome was the comparison of 1-year survival post-LTx between patients with PAH with preoperative LV DDF with patients with normal diastolic function (NDF). Our secondary outcomes were in-hospital mortality, the use of extracorporeal life support (ECLS) posttransplantation, duration of mechanical ventilation, ventilator-free days at 28 days (number of days without mechanical ventilation during the first 28 days posttransplantation, where patients who died while they were ventilated received a score of 0) (17), APACHE II score, Acute Physiology and Chronic Health Evaluation (APACHE) II score, intensive care unit length of stay (LOS), hospital LOS, and development of primary graft dysfunction (PGD) 72 hours post-LTx in all stages of PGD.
Pre-LTx demographic data and clinical status variables that were previously reported in the literature as significant for survival prediction postLTx (10, 11, (18) (19) (20) (21) (22) (23) were collected and compared. We also considered and compared other variables that are potentially related to DDF and outcomes after LTx, including age, body mass index (BMI), recipient and donor sex match, systemic hypertension, diabetes mellitus, and connective tissue disease (CTD). Standardized differences were compared between those with and without diastolic dysfunction. A standardized difference of 10% (generally viewed as a conservative threshold) was considered significant. These variables were also individually tested for an association with post-LTx mortality by using a univariate Cox proportional hazards regression analysis.
We used GraphPad software (GraphPad, San Diego, CA) and SPSS for Windows, version 19.0 (IBM SPSS Inc., Armonk NY). For our data analysis, the significance level was set at p < 0.05. Frequencies and proportions are reported for categorical variables, and continuous variables are shown as mean AE standard deviation (SD) or expressed by medians and IQR (25-75%) for non-normally distributed data. Comparisons were made by using Student t-test or Mann-Whitney U test for variables that were not normally distributed. To compare categorical variables, we used independent v 2 tests. Unadjusted, univariate analysis logistic regressions for 1 year and overall survival were performed by using the log-rank. A Cox proportional hazards regression provided an estimate of the hazard ratio (HR). The outcome was all-cause mortality, and data were right censored in December 2013. The odds ratios (ORs) between groups were calculated with 95% confidence intervals (95% CIs). In a multivariable Cox proportional hazard regression model, we included variables that were found to be significant in the univariate model, as well as age and sex. We excluded right atrial pressure from the multivariable model due to paucity of data (measurements were missing for >50% of the patients).
Results
Only DLTx is performed at our center for patients with PAH. We identified 116 patients from our database with PAH who underwent LTx between January 1995 and December 2013. After we applied inclusion and exclusion criteria, 44 patients were included in the final analysis (Figure 1) . Among the 44 patients, 14 (31.8%) patients had echocardiographic evidence of DDF before LTx. ). However, comorbidities were not different between the two groups. Patients with DDF had a trend toward a worse preoperative New York Heart Association functional class. Hemodynamics assessed through right heart catheterization showed a higher mean pulmonary artery pressure (mPAP) (54.6 AE 10 mmHg vs 47 AE 11.3 mmHg, p = 0.015) and right atrial pressure (RAP) (16.5 AE 5.2 mmHg vs 10.6 AE 5.2 mmHg, p = 0.04) in the DDF group. Seven patients were admitted to the ICU pretransplantation and were bridged to LTx with either pulmonary artery-to-left atrium Novalung Interventional Lung Assist device TM (Novalung GmbH, A Xenios company, Heilbronn, Germany) or ECMO (extracorporeal membrane oxygenation). This represented five of the 14 patients with DDF (p = 0.02). In composite, these pretransplantation characteristics suggest that the patients with diastolic dysfunction had a greater disease severity and worse cardiac function.
Patient characteristics pretransplantation
Post-LTx outcomes
Patients with diastolic dysfunction were more commonly treated with ECLS post-LTx (33% vs 7%, p = 0.02). Four patients in the DDF group had received bridging ECLS and one started veno-arterial ECLS postoperatively for hemodynamic worsening. Both patients in the NDF group who were on ECMO before transplantation were weaned in the operating room. However, other NDF patients were started on ECMO after surgery for oxygenation (1) and hemodynamic support (1) Table 2 ). There was no effect on development of grade II or III PGD. The intensive care unit, postoperative, and in-hospital survival rates did not differ between the two groups.
Six (43%) of the 14 patients with DDF died in the first year post-LTx. Two patients died from infectious complications, one patient had massive airway bleeding, one died from non-small cell lung carcinoma post-LTx, and one patient died from a stroke. For one patient, there were no data regarding the cause of death. Three (10%) patients in the NDF group died in the first year after LTx. The causes of death were cardiovascular event, humoral rejection, and fungal infection. Cox proportional hazards model analysis demonstrated a worse 1-year survival rate for patients with pre-LTx DDF compared with patients with NDF (HR 4.45, 95% CI 1.3-22, p = 0.02) (Figure 2 >1 year after transplantation). In the univariate analysis, DDF did not have significant effect on survival past 1 year. However, there was a trend to a worse survival past 1 year for patients with DDF (HR 2.3, 95% CI 0.8-7.4). We then chose to evaluate variables associated with overall survival. On a multivariate Cox regression analysis adjusted for age, sex, BMI, and mPAP (Table 3) , only DDF was significantly associated with overall survival (HR 5.4, 95% CI 1.3-22.0).
We tested the possibility that the implementation a strategy to bridge patients with PAH to LTx with ECLS in 2006 had an impact on the survival of patients with LV DDF. We divided the patients with DDF into two periods Percentage of patients in each NYHA functional class. Refers to the number of patients for whom we had data regarding NYHA classification (12 from the diastolic and 27 from the normal). Data are presented as number (%), mean and SD, or median and IQR. 2 Six patients had missing or incomplete hemodynamic data. 
Discussion
In this single center retrospective analysis of a consecutive cohort of patients with PAH, we showed that the presence of DDF adversely affected the early post-LTx outcome and 1-year survival. The reason for the latent effect is unclear and did not appear to be related to worse initial graft function. Our data suggests that patients with DDF were sicker post operatively and required more ECLS support. This more complicated early post-operative course may have translated into worse long-term outcome.
Despite the advance in the medical treatment of patients with PAH, many patients deteriorate and require LTx. Unfortunately, as for all LTx procedures, the post-LTx survival remains suboptimal with a median survival of 5 years (24, 25) . A higher early mortality in patients undergoing LTx has been reported for patients with PAH compared with patients with other diseases (26) . However, when the survival analysis was restricted to patients with PAH who survived the first 3 months, the survival rates were higher (1).
Defining patients with PAH with higher risk for worse outcome post-LTx is important for making the right clinical decisions such as the time for listing, pre-LTx support, the choice of the proper procedure, and follow-up pre-and post-LTx.
Previous studies assessed the impact of hemodynamic parameters such as cardiac index (23, 27) mPAP, and RV function (28) on LTx outcomes of patients with PAH. To the best of our knowledge, the effect of LV DDF pre-LTx has not been assessed specifically as a predictors of post-LTx outcome in patients with PAH. Porteous et al (29) recently completed a thoughtful retrospective analysis of the effect of DDF on primary graft function after LTx in 107 patients. They found that patients with DDF had a higher risk for primary graft dysfunction. However, they did not specifically evaluate the effects in patients with PAH and did not comment on changes in diastolic function after transplantation. The RV has a remarkable ability to recover over time after medical and surgical interventions (6, 30) . Our study did not systematically evaluate LV diastolic function over time in the entire cohort. Therefore, whether a similar improvement in LV diastolic function occurs over longer periods is unclear.
The patients with DDF had higher mPAP and RAP values before LTx and more often required ECLS as a bridge for LTx. This was not unexpected considering the severity of their primary disease. Whether the DDF resulted from impaired RV function or was the result of the chronic adverse influence of a dilated RV on LV filling is unclear. It is worth noting that patients with DDF had higher BMI compared with patients without diastolic dysfunction. Potentially, these patients may have had additional risk factors for DDF. However, BMI is less likely to be the cause for the DDF because these patients did not have evidence of DDF at the time of their PAH diagnosis. Potentially, the higher BMI in this group of patients may have been related to fluid accumulation from RV failure as opposed to an increase in body fat or metabolic syndrome.
Interestingly, we found that 1-year survival was significantly worse in patients with DDF. Differences in survival between the two groups became evident during the first months after transplantation, but not immediately postLTx while they were still in hospital, and became significant after 1 year (Figure 2 ). The importance of diastolic function as either a direct or an indirect contributor is supported in our multivariable Cox regression analysis. Diastolic dysfunction remained a significant risk even after the inclusion of variables that were previously reported in the literature as significant for prediction post-LTx survival (10, 19, 20) and other variables that are potentially related to diastolic function.
Patients with DDF appeared to be sicker and required more support after transplantation. ECLS support, APACHE II score, and ventilator-free days were all worse for patients with DDF. Surprisingly, however, there was no correlation between DDF and the development of PGD. This is surprising because one would have anticipated that higher left atrial pressure would have led to an increase in hydrostatic pressure and to the development of pulmonary edema. Indeed, this was the explanation provided in the study by Porteous et al (29) , who found that DDF was an independent risk factor for the development of grade III PGD in a cohort of their patients after LTx. Additionally none of the deaths in our study appeared to be directly related to hemodynamic instability or cardiac dysfunction. Consequently, a causal relationship between DDF and death in our cohort is difficult to reconcile. Potentially, the worse perioperative course led to a worse long-term outcome and contributed to some of the morbid events that led to death in the patients.
Our study has several limitations but should serve to incentivize future research in this area. This is a singlecenter retrospective study evaluating a small number of patients. Diastolic dysfunction pre-LTx was defined by echocardiography parameters done as part of the routine evaluation of patients at time of listing for LTx. We relied on reports of echocardiographic data and did not conduct a systematic review of the echocardiographic images as many of the images were purged after 10 years. We recognize that both of methods we used to quantify diastolic function have inherent limitations. Inconsistent echocardiographic assessment of RV systolic and diastolic function parameters over the period of observation also precluded incorporation of these parameters into our model. We also had inconsistent measurement/recording of RA pressure -another variable known to relate to RV function. Finally there was no follow-up protocol to evaluate systemically evaluate cardiac function after LTx. Echocardiograms were done at different time intervals after surgery based upon clinical need. This limited our ability to properly evaluate the changes in diastolic function over time. Further studies are therefore warranted to confirm our findings.
Conclusion
Diastolic dysfunction has a significant negative impact on outcomes after double lung transplantation for PAH. In our cohort of patients with PAH, left ventricular diastolic dysfunction was associated with a more complicated post-operative clinical course. There was no association between diastolic dysfunction and primary graft dysfunction, however these patients received ECLS bridging to transplantation and required ECLS more commonly after surgery for hemodynamic support. Diastolic dysfunction was an independent risk factor for death in the first year after transplantation. The reason for this association remains speculative and requires further study.
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